Showing reports 11 - 15 of 15 in category Nanomedicine:

Nanotechnology in Medical Applications. State of the art in materials and devices
Source: Department of Pharmaceutical Affairs and Medical Technology of the Dutch Ministry of Health, Welfare and Sports – Publication date: October 2005
	This report presents the state-of-the-art in the area of promising nanotechnology approaches for medical technology. In particular, relevant applications are reported in surgery, cancer diagnosis and therapy, biodetection of disease markers, molecular imaging, implant technology, tissue engineering, and devices for drug, protein, gene, and radionuclide delivery.

Nanotechnology in Medical Applications: Possible Risks for Human Health
Source: Department of Pharmaceutical Affairs and Medical Technology of the Dutch Ministry of Health, Welfare and Sports – Publication date: October 2005
	This report recommends the development of specific guidance documents at a European level for the safety evaluation of nanotechnology products applied in medical technology is strongly recommended and the need for further research in the field of nanotoxicology is clearly identified.

Opinion on the Ethical Aspects of Nanomedicine
Source: European Commission – Publication date: June 2006
	This report by the European Group on Ethics (EGE), an independent and multidisciplinary body which advises the European Commission on ethical aspects of science and new technologies, is a summary of the presentations and discussions on the topic of Nanomedicine, which took place in Brussels, Belgium on March 21, 2006.

Shining a Light on Cancer Research
Source: NCI Alliance for Nanotechnology in Cancer – Publication date: February 2005
	Quantum dots and nanoshells are driving development of novel analytical and therapeutic approaches for cancer.

The Nanotechnology-Biology Interface: Exploring Models for Oversight
Source: Humphrey Institute of the University of Minnesota – Publication date: September 2005
	The Center for Science, Technology & Public Policy at the Humphrey Institute of the University of Minnesota hosted a workshop on September 15, 2005 to explore and evaluate models for the oversight of nanotechnology, with a focus on nanoparticles that are used in or derived from biological systems. Over 160 people attended the workshop, including individuals from industry, academe, national organizations, and federal, state and local government. This is the report summarizing the workshop.